INS and metabolic dysfunction-associated steatotic liver disease: Expression of SPP1 was significantly correlated with liver fat (r = 0.42) and fS-insulin (r = 0.43) (both p < 0.05), suggesting a role in the pathogenesis of insulin resistance syndrome, including nonalcoholic fatty liver disease.